A Single-Centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four Period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600mg and 150mg) on QT/QTc Interval, Compared to Placebo, using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers A Single-Centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four Period Crossover S ...
A Single-Centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four Period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600mg and 150mg) on QT/QTc Interval, Compared to Placebo, using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers A Single-Centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four Period Crossover S ...
A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the ...
A Single-centre, Double-blind, Double-dummy, Randomised, Placebo-controlled, Four-period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600 mg and 150 mg) on QT/QTc Interval, Compared to Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers A Single-centre, Double-blind, Double-dummy, Randomised, Placebo-controlled, Four-period Crossover S ...